Related Experiment Video
Updated: Jun 14, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Selection of long acting reversible contraception methods by emergency contraception clients: A prospective
Gentry Carter1, Misha Pangasa1, Corinne D Sexsmith1
1ASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Objectives:
To describe long acting reversible contraception (LARC) initiation in emergency contraception (EC) visits.
Study Design:
EC clients age 18-35 years at four Utah family planning clinics between February 2021 and April 2023 chose between oral EC and three LARC options.
Results:
Of 2106 EC clients approached, 306 (14.5%) requested LARC and 293 initiated a device: 160 (55%) an etonogestrel implant+ oral levonorgestrel (LNG), 72 (25%) a copper intrauterine device (IUD), and 61 (21%) a 52 mg levonorgestrel IUD (p < 0.001).
Conclusions:
In this observational study, one in seven EC clients initiated a LARC method and more frequently selected the etonogestrel implant with oral levonorgestrel over an IUD.
Clinical Trial Registration:
Clinicaltrials.gov NCT04678817; registered 12/16/20.
Related Concept Videos
Birth Control Methods
Drug Delivery: Enteral Route
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Depolarizing Blockers: Pharmocokinetics

